Mayo Clinic Proceedings Home

Burden and Timing of Hospitalizations in Heart Failure: A Community Study

      Abstract

      Objective

      To study the temporal distribution and causes of hospitalizations after heart failure (HF) diagnosis.

      Patients and Methods

      Hospitalizations were studied in 1972 Olmsted County, Minnesota, residents with incident HF from January 1, 2000, to December 31, 2011. All hospitalizations were examined for the 2 years following incident HF, and each was categorized as due to HF, other cardiovascular causes, or noncardiovascular causes. Negative binomial regression examined associations between time periods (0-30, 31-182, 183-365, and 366-730 days after diagnosis) and hospitalizations.

      Results

      During the 2 years after diagnosis, 3495 hospitalizations were observed among 1336 of the 1972 patients with HF. The age- and sex-adjusted rates of hospitalizations were highest in the first 30 days after diagnosis (3.33 per person-year vs 1.33, 1.07, and 1.00 per person-year for 31-182 days, 183-365 days, and 366-730 days, respectively). The rates of hospitalizations were similar across sex, presentation of HF (inpatient or outpatient), and type of HF (preserved or reduced ejection fraction). Patients diagnosed as inpatients who had long hospital stays (>5 days) experienced more than a 30% increased risk of rehospitalization within 30 days of dismissal. Importantly, most hospitalizations (2222 of 3495 [63.6%]) were due to noncardiovascular causes, and a minority (440 of 3495 [12.6%]) were due to HF. The rates of noncardiovascular hospitalizations were higher than those for HF or other cardiovascular hospitalizations across all follow-up for all time periods after HF.

      Conclusion

      Patients with HF experience high rates of hospitalizations, particularly within the first 30 days, and mostly for noncardiovascular causes. To reduce hospitalizations in patients with HF, an integrated approach focusing on comorbidities is required.

      Abbreviations and Acronyms:

      EF ( ejection fraction), HF ( heart failure), ICD-9-CM ( International Classification of Diseases, Ninth Revision, Clinical Modification), LVEF ( left ventricular EF)
      To read this article in full you will need to make a payment

      References

        • Heidenreich P.A.
        • Albert N.M.
        • Allen L.A.
        • et al.
        • American Heart Association Advocacy Coordinating Committee
        • Council on Arteriosclerosis, Thrombosis and Vascular Biology
        • Council on Cardiovascular Radiology and Intervention
        • Council on Clinical Cardiology
        • Council on Epidemiology and Prevention
        • Stroke Council
        Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association.
        Circ Heart Fail. 2013; 6: 606-619
        • Go A.S.
        • Mozaffarian D.
        • Roger V.L.
        • et al.
        • American Heart Association Statistics Committee and Stroke Statistics Subcommittee
        Heart disease and stroke statistics—2014 update: a report from the American Heart Association.
        Circulation. 2014; 129: e28-e292
        • Chun S.
        • Tu J.V.
        • Wijeysundera H.C.
        • et al.
        Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure.
        Circ Heart Fail. 2012; 5: 414-421
        • Dharmarajan K.
        • Hsieh A.F.
        • Kulkarni V.T.
        • et al.
        Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia: retrospective cohort study.
        BMJ. 2015; 350: h411
        • Dharmarajan K.
        • Hsieh A.F.
        • Lin Z.
        • et al.
        Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia.
        JAMA. 2013; 309: 355-363
        • Sangaralingham L.R.
        • Shah N.D.
        • Yao X.
        • Roger V.L.
        • Dunlay S.M.
        Incidence and early outcomes of heart failure in commercially insured and Medicare Advantage patients, 2006 to 2014.
        Circ Cardiovasc Qual Outcomes. 2016; 9: 332-337
        • Gerber Y.
        • Weston S.A.
        • Redfield M.M.
        • et al.
        A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010.
        JAMA Intern Med. 2015; 175: 996-1004
        • Rocca W.A.
        • Yawn B.P.
        • St Sauver J.L.
        • Grossardt B.R.
        • Melton III, L.J.
        History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population.
        Mayo Clin Proc. 2012; 87: 1202-1213
        • St Sauver J.L.
        • Grossardt B.R.
        • Leibson C.L.
        • Yawn B.P.
        • Melton III, L.J.
        • Rocca W.A.
        Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project.
        Mayo Clin Proc. 2012; 87: 151-160
        • St. Sauver J.L.
        • Grossardt B.R.
        • Yawn B.P.
        • Melton III, L.J.
        • Rocca W.A.
        Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester Epidemiology Project.
        Am J Epidemiol. 2011; 173: 1059-1068
        • St Sauver J.L.
        • Grossardt B.R.
        • Yawn B.P.
        • et al.
        Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system.
        Int J Epidemiol. 2012; 41: 1614-1624
        • Dunlay S.M.
        • Redfield M.M.
        • Weston S.A.
        • et al.
        Hospitalizations after heart failure diagnosis: a community perspective.
        J Am Coll Cardiol. 2009; 54: 1695-1702
        • Roger V.L.
        • Weston S.A.
        • Redfield M.M.
        • et al.
        Trends in heart failure incidence and survival in a community-based population.
        JAMA. 2004; 292: 344-350
        • Ho K.K.
        • Anderson K.M.
        • Kannel W.B.
        • Grossman W.
        • Levy D.
        Survival after the onset of congestive heart failure in Framingham Heart Study subjects.
        Circulation. 1993; 88: 107-115
        • Roger V.L.
        • Weston S.A.
        • Gerber Y.
        • et al.
        Trends in incidence, severity, and outcome of hospitalized myocardial infarction.
        Circulation. 2010; 121: 863-869
        • Charlson M.E.
        • Pompei P.
        • Ales K.L.
        • MacKenzie C.R.
        A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.
        J Chronic Dis. 1987; 40: 373-383
        • Deyo R.A.
        • Cherkin D.C.
        • Ciol M.A.
        Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.
        J Clin Epidemiol. 1992; 45: 613-619
        • Levey A.S.
        • Coresh J.
        • Greene T.
        • et al.
        • Chronic Kidney Disease Epidemiology Collaboration
        Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate.
        Ann Intern Med. 2006; 145 ([published correction appears in Ann Intern Med. 2008;149(7):519]): 247-254
        • Yturralde R.F.
        • Gaasch W.H.
        Diagnostic criteria for diastolic heart failure.
        Prog Cardiovasc Dis. 2005; 47: 314-319
        • Levy D.
        • Kenchaiah S.
        • Larson M.G.
        • et al.
        Long-term trends in the incidence of and survival with heart failure.
        N Engl J Med. 2002; 347: 1397-1402
        • McCullough P.A.
        • Philbin E.F.
        • Spertus J.A.
        • Kaatz S.
        • Sandberg K.R.
        • Weaver W.D.
        Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study.
        J Am Coll Cardiol. 2002; 39: 60-69
        • Barker W.H.
        • Mullooly J.P.
        • Getchell W.
        Changing incidence and survival for heart failure in a well-defined older population, 1970-1974 and 1990-1994.
        Circulation. 2006; 113: 799-805
        • Chen J.
        • Normand S.L.
        • Wang Y.
        • Krumholz H.M.
        National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008.
        JAMA. 2011; 306: 1669-1678
        • Krumholz H.M.
        • Normand S.L.
        • Wang Y.
        Trends in hospitalizations and outcomes for acute cardiovascular disease and stroke, 1999-2011.
        Circulation. 2014; 130: 966-975
        • Ross J.S.
        • Chen J.
        • Lin Z.
        • et al.
        Recent national trends in readmission rates after heart failure hospitalization.
        Circ Heart Fail. 2010; 3: 97-103
        • Chamberlain A.M.
        • St Sauver J.L.
        • Gerber Y.
        • et al.
        Multimorbidity in heart failure: a community perspective.
        Am J Med. 2015; 128: 38-45
        • Fonarow G.C.
        • Stough W.G.
        • Abraham W.T.
        • et al.
        • OPTIMIZE-HF Investigators and Hospitals
        Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.
        J Am Coll Cardiol. 2007; 50: 768-777
        • O'Connor C.M.
        • Miller A.B.
        • Blair J.E.
        • et al.
        • Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) Investigators
        Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program.
        Am Heart J. 2010; 159 ([published correction appears in Am Heart J. 2012;163(5):900]): 841-849.e1